Compound Detail
CHEMBL4755916
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COC(=O)[C@H](NC(=O)CC/C(C)=C/Cc1c(O)c2c(c(C)c1OC)COC2=O)[C@H](C)O
Basic Information
| ChEMBL ID | CHEMBL4755916 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KWKRAZXMOCFDLV-LFUMKSLISA-N |
2
Targets
4
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
435.5
MW (Da)
1.69
ALogP
8
HBA
3
HBD
131.4
PSA (Ų)
0.39
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 5.05
IC50 2 meas. best 4.16
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | EC50 | = | 9000.0 | nM | 5.05 | Immunosuppression-mediated antiproliferative activity against anti-CD3/anti-CD28... | 32007665 |
| Jurkat | EC50 | = | 14000.0 | nM | 4.85 | Immunosuppression-mediated antiproliferative activity against human Jurkat T cel... | 32007665 |
| Unchecked | IC50 | = | 69000.0 | nM | 4.16 | Immunosuppression-mediated cytotoxicity against anti-CD3/anti-CD28-stimulated hu... | 32007665 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32007665 | 10.1016/j.ejmech.2020.112091 | Unchecked | 5 |
| 32007665 | 10.1016/j.ejmech.2020.112091 | Jurkat | 2 |
Data from ChEMBL 36 via Core Engine